Dr. Angelien

Kemna

Mandate and number of AXA shares

Appointed on April 23, 2024 – Term expires at the 2027 Shareholders’ Meeting
First appointment on April 27, 2016
Member to the AXA Audit Committee
Number of AXA shares held on December 31, 2023: 7,250

Expertise and experience

Dr. Angelien Kemna graduated with a Master of Arts in Econometrics and a Ph.D. in Finance from Erasmus University Rotterdam (The Netherlands). She was a visiting scholar at the Sloan School, MIT (United States). Dr. Angelien Kemna began her career as Associate Professor in Finance at the Erasmus University from 1988 to 1991. In 1992, she joined Robeco NV and held various positions, notably Investments and Account Management Director from 1998 to 2001. During this period, she was also part-time Professor of Financial Markets at the University of Maastricht (The Netherlands) (1993–1999). From 2001 to July 2007, she worked for ING Investment Management BV (The Netherlands), where she initially held the position of Global Chief Investment Officer and subsequently Chief Executive Officer for the European Region. In the period 2007-2011, Dr. Angelien Kemna was part-time Professor of corporate governance at the Erasmus University and had also various non-executive and advisory positions, most notably Vice-Chairwoman of the Supervisory Board of the Dutch regulatory institution (AFM). In 2009, Dr.  Angelien Kemna joined APG group NV as member of the Executive Board with the responsibility of Chief Investment Officer. From September 2014 to November 2017, Dr. Angelien Kemna was Chief Finance & Risk Officer of APG group (The Netherlands).

Mandates held within the AXA Group

• Director: AXA, AXA Investment Managers (Senior Independent Director)

Mandates held outside the AXA Group

• Director or member of the Supervisory Board: NIBC (The Netherlands), Naspers (South Africa), Prosus (The Netherlands)

Mandate held during the last five years

• Director: Friesland Campina N.V. (The Netherlands)